Considering the proliferative role of SDF-1/CXCR4 axis in breast tumors [27, 28] and the promising in vitro results obtained with CXCR4 inhibitors, the expression of the SDF-1 receptor was also evaluated in feline mammary carcinomas. This evidence concerns the gene CXCL12 and breast neoplasm.